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ABSTRACT 
Background: Cases of fetal hydrothorax (FHT) are rare, with an occurrence 
probability of 1 in every 10,000-15,000 pregnancies. The condition may remain 
undiagnosed, and the fetus may be aborted, or death may occur soon after birth in 
outlying hospitals before transfer to a tertiary care center. The incidence rate of FHT 
is higher in males than females (2:1). One of the most effective methods of 
diagnosing fetal hydrothorax is sonography. Three forms of currently available 
treatments are: thoracentesis, thoracoamniotic shunting (TAS), and thoracomaternal 
cutaneous drainage. Fetal outcomes could be improved by performing the 
Extrauterine Intrapartum Treatment (EXIT) procedure 
Case Presentation: We present two cases of first pregnancy primary FHT. In the 
first case, a 24-year-old woman was diagnosed with asymptomatic FHT in the 28th 
week of gestation without any prior history. In the second case, a 22-year-old woman 
with poor medical history was diagnosed in the 35th week of pregnancy and was 
experienced difficulty of breathing. Both pregnancies were delivered by cesarean 
section based on obstetric indications. Thoracentesis was performed on both 
neonates, and pathological examination of the pleural fluid was conducted. However, 
they died shortly after birth. 
Conclusion: The EXIT procedure is still a challenging method. A fetus with FHT 
is at significant risk of pulmonary hypoplasia and respiratory distress following 
delivery. Early diagnosis and intervention of FHT are vital to ensure a good 
prognosis. Approaching multidisciplinary groups, providing supportive diagnostic 
facilities and financial support is essential in improving fetal outcomes and 
preventing FHT in subsequent pregnancies.  
 






The term fetal hydrothorax describes fluid 
accumulation in the pleural cavity area, either 
unilaterally or bilaterally.1,2,3 Cases of fetal 
hydrothorax (FHT) are rare, with a probability of 
occurring in 1 out of every 10,000-15,000 
pregnancies.13,15 The incidence of primary FHT may 
be even higher, considering that the condition may 
remain undiagnosed in many cases. Primary FHT 
may resolve spontaneously. The fetus may be 
aborted, or death may occur soon after birth in 
outlying hospitals before transfer to a tertiary care 
center.2,3,6 The incidence rate for FHT is higher in 
males than females (with a ratio of 2:1).4,5 Cases of 
FHT occur due to primary or secondary chylous 
leaks from fluid retention related to immune or non-
immune hydrops. One of the most effective methods 
of diagnosing FHT is sonography. Although the 
earliest gestational age at which prenatal diagnosis 
has been made using sonography is 17 weeks, most 
cases are not detected until after 30 weeks.3 Upon 
discovery, cases of FHT can be managed 
conservatively or actively through the fetus. There 
are three forms of treatment available for managing 
fetuses with FHT: thoracentesis, thoracoamniotic 
shunting (TAS), and thoracomaternal cutaneous 
drainage. However, all three options do not provide 
a high fetal survival rate and likely interfere with the 
pregnancy condition.3,7,10 The Extrauterine 
Intrapartum Treatment (EXIT) provides alternative 
to improve the neonatal outcomes. In this report, we 
will present two cases, both of which are first-time 
pregnancies at 36 weeks of gestation that have been 
diagnosed with FHT. 
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2. Case Presentation 
Case 1 
 A 24-year-old married woman with G1P0A0 
was in the 36th week of gestation. She lived in 
Semarang, Central Java, Indonesia. She was an 
inpatient at Dr. Kariadi Hospital in Semarang at the 
time of the study. There was no record of known 
illnesses in her medical history. However, there was 
no complete medical examination. The antenatal care 
was routinely performed without any complication. 
However, on her gestational age of 28 weeks, the 
fetus was diagnosed with FHT using ultrasound. 
Afterward, the fetal condition was observed every 1-
2 weeks. Unfortunately, the patient discontinued her 
antenatal care until she felt the onset of contractions 
and admitted in the emergency department due to 
premature labor at 36 weeks of gestation. We 
performed an emergency caesarean section with 
informed consent from the patient. The caesarean 
section operation was conducted successfully; 
however, the baby did not cry immediately upon 
delivery. The Perinatology team immediately 
performed resuscitation.  
 The newborn's weight was 3200 grams with 
an APGAR score of one in the 1st, 5th, and 10th 
minute. After the resuscitation was completed, the 
Thoracic Vascular Surgery team performed 
thoracentesis. At the time of the procedure, ± 110 cc 
of serosa fluid from the left side of the thorax and 40 
cc haemorrhagic serosa fluid from the right side of 
the thorax was removed. Further anatomical 
pathology examinations identified the fluid as 
lymphocytic effusion. After receiving treatment, the 
baby was placed into the neonatal intensive care unit 
(NICU) and died 30 minutes later. 
Case 2 
 A 22-year-old married woman with G1P0A0 
was in the 36th week of gestation and lived in Jepara, 
Central Java, Indonesia. This patient was referred to 
RSUP Dr. Kariadi due to polyhydramnios at 35 
weeks of gestation accompanied with difficulty of 
breathing. On her first visit to our center, her 
pregnancy was diagnosed with FHT. The patient was 
then followed up by a multidisciplinary team 
consisting of Obstetrics and Gynaecology, 
Perinatology, and Vascular Thoracic Surgery. The 
patient was planned for an elective caesarean section 
with EXIT procedure at the 38th week of gestation. 
Corticosteroid course (dexamethasone 6 mg/12 h for 
two days) to accelerate the fetal lung maturation was 
given. However, due to the ruptured of the 
membrane, patient entering the state of labor, the 
team eventually decided to conduct an emergency 
caesarean section in the 36th week of gestation. The 
caesarean section operation was successful, and the 
baby began to cry weakly upon delivery. The 
perinatology team immediately performed 
resuscitation.  
The newborn's weight was 2750 grams with an 
APGAR score of seven at the 1st minute, eight at the 
5th minute, and nine at the 10th minute. Once the 
Perinatology team had completed the resuscitation, 
the Thoracic Vascular Surgery team performed an 
ultrasound-guided thoracentesis on the baby's left 
thorax. At the time of the procedure, the fluid 
consisted of 40 cc serous fluid, and daily fluid 
aspiration evaluations in the NICU unit were 
scheduled with a maximum of 50 cc aspiration. The 
results from anatomical pathology examinations 
identified the fluid caused by nonspecific 
inflammation and did not discover any malignancies. 
After four days of treatment, saturation levels in the 
newborn were only around 80%. Unfortunately, the 
baby was declared dead the next day. 
3. Discussion 
The two cases were different from the point of 
view of diagnosis, symptoms in pregnancy, and the 
antepartum interventions. The first case was 
diagnosed in the 28th week of gestation. The 
evaluation of the fetus then ensued after considering 
several factors, such as the absence of hydramnios. 
We expected a spontaneous resolution of the fluid in 
the fetal thorax cavity; however, there was never any 
sign of a decrease in fluid level. The second case was 
diagnosed near the early term even after a possible 
congenital fetal condition was suggested in the 
secondary health facility due to the detection of 
polyhydramnios. The symptom of shortness of breath 
that the second patient reported could be accounted 
for by the presence of these polyhydramnios, 
something that she had thought to be expected in 
pregnancy.  
In addition to the diagnosis, the interventions of 
both cases were also distinct. The first patient was not 
given corticosteroid to help fetal lung maturation due 
to negligence of routine antenatal care after the 
diagnosis of FHT was made. The second patient was 
given a corticosteroid course of dexamethasone 6 mg 
every 12 hours for two days intramuscularly. Even 
though antenatal interventions were not conducted, 
thoracentesis was performed promptly after the 
fetuses were born in an attempt to improve prognosis. 
Although both newborns eventually died, the 
distinction was seen in the survival duration. Unlike 
the first newborn who died immediately after birth, 
the second newborn managed to survive for four days 
in the NICU, where he eventually died due to many 
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complications of FHT. An extrauterine intrapartum 
treatment (EXIT) procedure had been discussed as a 
possibility for both babies. EXIT is a management 
strategy that allows interventions on a neonate 
delivered from the uterus with fetoplacental 
circulation preserved and it is a novel technique 
which provides a therapeutic option for fetuses 
with a variety of potentially fatal anomalies, 
particularly airway anomalies.12 However, the 
attempt of EXIT procedure was failed to prolong the 
survival of the baby in the second case. After we 
conducted discussion and examinations to determine 
the primary cause of death, it was concluded that both 
cases were different. The first newborn died from 
respiratory disorder (Persistent Pulmonary 
Hypertension of the Newborn (PPHN)), and the 
second baby succumbed to the complication of Total 
Anomalous Pulmonary Venous Drainage (TAPVD) 
that also caused a respiratory disorder (PPHN).  
The natural history of FHT is significantly 
different from that of chylothorax in newborns and 
carries a much poorer prognosis. The mortality rate 
for chylothorax in newborns is 15% at most, while 
the mortality rate for prenatally diagnosed FHT is 
53%.2,5,16 However, this should also be separated 
from the finding that several characteristics of 
primary FHT are associated with a more favorable 
outcome. For example, unilateral FHT without 
evidence of tension such as mediastinal shift or 
diaphragmatic eversion is associated with 100% 
survival.2,3 However, this differed with the survival 
rate of merely 52% in bilateral FHT.2 Survival was 
also observed in all cases of FHT that spontaneously 
resolve, which occurred in approximately 5% to 22% 
of cases.2,14,17-22 Nonetheless, due to the possibility of 
a positive-spontaneous regression, a period of 
observation is required in each case of FHT.7 
Early diagnosis in fetal hydrothorax might help 
the management of pregnancy and also the fetus. 
Several measures can be taken once we successfully 
diagnose FHT. Prenatal karyotyping is 
recommended, especially if fetal intervention is 
considered. The incidence of Down syndrome in FHT 
is 4.9%.6 Since the incidence of associated congenital 
heart disease may be as high as 5%; we recommend 
that every fetus diagnosed with FHT undergoes fetal 
echocardiography.23 We also recommend that these 
pregnancies be followed closely, with ultrasound 
examinations every 1 to 2 weeks for early detection 
of signs consistent with tension hydrothorax such as 
mediastinal shift, diaphragmatic eversion, 
development of hydrops, and polyhydramnios.7 
The management of pleural effusion in a fetus is 
highly complicated, with the difficulty of 
distinguishing the fetal pleural effusion between 
primary and secondary FHT. Secondary FHT is much 
more common in fetuses than in infants.1,3 Secondary 
FHT may be caused by a wide variety of maternal and 
fetal disorders, including chromosomal anomalies; 
cardiovascular, hematologic, gastrointestinal, 
pulmonary, metabolic, infectious, and neoplastic 
disorders; and malformations of the placenta and the 
umbilical cord.3,4,9-11 Such cases are also a challenge 
for obstetricians and gynaecologists to diagnose. 
Theoretically, the diagnosis can be made in the 30th 
week of gestation.3 To distinguish the leading cause 
of whether FHT is primary or secondary, a study 
demonstrated that 40% of secondary FHT cases had 
major congenital abnormalities in the fetus, which 
were detected using sonographic examinations.3,22 
Some cases still required fetal thoracentesis to 
distinguish primary from secondary FHT.5 However, 
no underlying causes were found in most cases of 
fetal hydrothorax.7  
If the diagnosis is late or there is no intervention 
in early pregnancy after a diagnosis of FHT, fetuses 
will suffer a significant risk of pulmonary hypoplasia 
and respiratory distress following delivery. We 
recommend that fetuses with a large pleural effusion 
be transferred to and delivered within a tertiary care 
center. Prenatal consultations with a pediatric 
surgeon, neonatologist, geneticist, and pediatric 
cardiologist are also recommended. The presence of 
FHT does not influence the mode of delivery, and 
cesarean delivery should be performed based on 
obstetric indications.  
Several fetal management options can be taken 
when pregnancy with FHT is diagnosed. During 
pregnancy, a thoracoamniotic shunt (TAS) can be 
inserted. However, in Indonesia, this procedure can 
only be carried out at the Harapan Kita Mother and 
Child Hospital in Jakarta. Once the baby is born, the 
options are to do either extrauterine intrapartum 
treatment (EXIT) or thoracentesis. The EXIT 
procedure is performed when the baby is born before 
cutting the umbilical cord, while thoracentesis is done 
after cutting the umbilical cord, with the EXIT 
survival rate reaching up to 100% in some case 
series.24 In a case report of non-hydrops cases, the 
survival rate was reported to be high. However, there 
was no significant difference between taking any 
action versus taking no action (98.1% survival rate 
without fetal therapy, 96.3% with thoracentesis, 
100% with TAS). The difference in survival rates 
between EXIT and thoracentesis procedures has 
never been mentioned in previous literature. Some 
neonatologists believe that prenatal decompression is 
closely related to the rate of resuscitation required in 
newborns.9,26 There are no data to support this claim, 
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although it was suggested that delaying thoracentesis 
until delivery reduces fetal and maternal risk. 
According to previous studies, out of 287 cases 
of primary FHT, the survival rate for cases with 
hydrops was 58.0% (113/195) versus non-hydrops at 
97.8% (90/92). The survival rate in hydropic cases for 
the group of patients without therapy was 59.7% 
(40/67), 51.5% (35/68) for those with thoracentesis, 
and 63.3% (38/60) in those who received 
thoracoamniotic shunting (TAS), while in non-
hydropic cases the survival rates were 98.1% (53/54) 
for those who received no therapy, 96.3% (26/27) for 
thoracentesis, and 100% (11/11) with TAS. 
Therefore, the most highly recommended therapy in 
primary FHT is thoracoamniotic shunting (TAS) as a 
procedure with the highest survival rate.25 
There are several take-home points from the two 
cases that have been presented. Early diagnosis 
followed by early interventions may increase the 
prognosis of fetal outcomes. The attempt to evaluate 
the fetal hydrothorax with imaging proved 
challenging, especially regarding ultrasound. In 
theory, FHT may be diagnosed as early as the 
17th week of pregnancy. Nonetheless, in these 
two cases, both FHT was diagnosed in the 3rd 
trimester. The management was further 
complicated by the regulation required to 
perform EXIT. Prior simulations and training are 
also compulsory for the health workers involved 
in the procedure. The application of shunt in 
pregnancy with FHT as a compounding 
complication is still difficult even for OB/GYN 
colleagues, whereas it is necessary to ameliorate 
the fetal prognosis. The patients also experienced 
predicaments in transferring to tertiary health 
facilities due to the location of residence and the 
lack of transportation methods. This problem 
was particularly true for the second patient, in 
which the city she resides is different from her 
primary care facility is situated. Furthermore, the 
tertiary care center location, RSUP Dr. Kariadi, 
is located in a different city from both her 
residence and primary care. At the end of care, 
both patients were content with the pregnancy 
and felt relieved from delivery management, 
allowing them to go back to daily activities soon. 
They hoped that health workers could help them 
plan their subsequent pregnancies to reduce the 
risk of occurrence equal to this pregnancy and 
have healthy newborns in the future. 
 
 
Figure 1.Algorithm for the management of fetal pleural effusions. 
(taken from Thoracoamniotic Shunting for Fetal Hydrothorax: 
Predictors of Intrauterine Course and Postnatal Outcome.)7 
 
 
Figure 2.Diagnostic ultrasound at 28th weeks of gestation (Case 
1) 
 
Figure 3. Ratio fetal hydrothorax male to female 2:1 (Case 1) 
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Figure 4.Ratio fetal hydrothorax male to female 2:1 (Case 1) 
 
 
Figure 5. Fetal thoracocentesis 
4. Conclusion 
 Cases of Fetal Hydrothorax are sporadic 
and closely related to fetal outcomes. Pregnancy 
itself can be highly complicated if there is 
abortion, polyhydramnios, fetal death in the 
womb, preterm labor, or congenital 
abnormalities occurring in the fetus such as 
Down syndrome or congenital heart 
abnormalities. However, the possibility of 
spontaneous resolution should be considered as a 
significant factor in some cases. In this study, 
FHT was more commonly found in male fetuses. 
Both cases also experienced preterm labor. 
Bilateral FHT could only be identified after birth 
due to the difficulty of intrapartum detection 
with imaging. This delay in diagnosis resulted in 
poor newborn outcomes despite the subsequent 
high-level management given in tertiary 
healthcare facilities. Consequently, newborns 
from the first and second cases died within 30 
minutes and four days after birth, respectively. In 
the future, early diagnosis and intervention of 
FHT are vital to ensure a good prognosis. 
Approaching multidisciplinary groups and 
providing supportive diagnostic facilities, 
sources of financial support, and antenatal care 
discipline are essential in optimizing fetal 
outcomes and preventing pregnancy with FHT in 
subsequent pregnancies. 
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